Cite

HARVARD Citation

    Fedorova, L. et al. (n.d.). 97P Toxicity of bispecific antibody glofitamab in patients with aggressive B-cell non-Hodgkin lymphoma in real clinical practice. Immuno-oncology technology. p. . [Online]. 
  
Back to record